123 related articles for article (PubMed ID: 12047415)
1. Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora.
Nord CE; Gajjar DA; Grasela DM
Clin Microbiol Infect; 2002 Apr; 8(4):229-39. PubMed ID: 12047415
[TBL] [Abstract][Full Text] [Related]
2. Ecological effect of gatifloxacin on the normal human intestinal microflora.
Edlund C; Nord CE
J Chemother; 1999 Feb; 11(1):50-3. PubMed ID: 10078781
[TBL] [Abstract][Full Text] [Related]
3. Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.
Nord CE; Meurling L; Russo RL; Bello A; Grasela DM; Gajjar DA
J Chemother; 2003 Jun; 15(3):244-7. PubMed ID: 12868550
[TBL] [Abstract][Full Text] [Related]
4. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.
Oh H; Nord CE; Barkholt L; Hedberg M; Edlund C
Infection; 2000 Sep; 28(5):272-7. PubMed ID: 11073132
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.
Edlund C; Beyer G; Hiemer-Bau M; Ziege S; Lode H; Nord CE
Scand J Infect Dis; 2000; 32(1):81-5. PubMed ID: 10716083
[TBL] [Abstract][Full Text] [Related]
6. Impact of gemifloxacin on the normal human intestinal microflora.
Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
J Chemother; 2001 Feb; 13(1):47-51. PubMed ID: 11233800
[TBL] [Abstract][Full Text] [Related]
7. Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model.
Gismondo MR; Drago L; Lombardi A; Fassina C; Cesana M
Chemotherapy; 1995; 41(4):281-8. PubMed ID: 7555209
[TBL] [Abstract][Full Text] [Related]
8. The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
Weller TM; Andrews JM; Jevons G; Wise R
J Antimicrob Chemother; 2002 Jan; 49(1):177-84. PubMed ID: 11751785
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
van Nispen CH; Hoepelman AI; Rozenberg-Arska M; Verhoef J; Purkins L; Willavize SA
Am J Surg; 1998 Dec; 176(6A Suppl):27S-31S. PubMed ID: 9935254
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinolones on intestinal ecology.
Edlund C; Nord CE
Drugs; 1999; 58 Suppl 2():65-70. PubMed ID: 10553709
[TBL] [Abstract][Full Text] [Related]
11. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.
Lode H; Von der Höh N; Ziege S; Borner K; Nord CE
Scand J Infect Dis; 2001; 33(12):899-903. PubMed ID: 11868762
[TBL] [Abstract][Full Text] [Related]
12. Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Gradelski E; Valera L; Kolek B; Bonner D; Fung-Tomc J
Int J Antimicrob Agents; 2001 Jul; 18(1):43-8. PubMed ID: 11463525
[TBL] [Abstract][Full Text] [Related]
13. Effect of lomefloxacin on the normal oral and intestinal microflora.
Edlund C; Brismar B; Nord CE
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):35-9. PubMed ID: 2303064
[TBL] [Abstract][Full Text] [Related]
14. Impact of ticarcillin/clavulanate on the intestinal microflora.
Nord CE; Bergan T; Thorsteinsson SB
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():221-6. PubMed ID: 2606816
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
Wu P; Lawrence LE; Denbleyker KL; Barrett JF
Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
[TBL] [Abstract][Full Text] [Related]
16. Effect of tigecycline on normal oropharyngeal and intestinal microflora.
Nord CE; Sillerström E; Wahlund E
Antimicrob Agents Chemother; 2006 Oct; 50(10):3375-80. PubMed ID: 17005820
[TBL] [Abstract][Full Text] [Related]
17. Effect of telavancin on human intestinal microflora.
Rashid MU; Weintraub A; Nord CE
Int J Antimicrob Agents; 2011 Dec; 38(6):474-9. PubMed ID: 21982049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
[TBL] [Abstract][Full Text] [Related]
19. Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.
Schmitz FJ; Boos M; Mayer S; Jagusch H; Fluit AC
J Antimicrob Chemother; 2002 Feb; 49(2):283-7. PubMed ID: 11815569
[TBL] [Abstract][Full Text] [Related]
20. Effect of piperacillin/tazobactam therapy on intestinal microflora.
Nord CE; Brismar B; Kasholm-Tengve B; Tunevall G
Scand J Infect Dis; 1992; 24(2):209-13. PubMed ID: 1322559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
